Does CAPMATINIB Cause Peripheral swelling? 283 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 283 reports of Peripheral swelling have been filed in association with CAPMATINIB (TABRECTA). This represents 12.3% of all adverse event reports for CAPMATINIB.
283
Reports of Peripheral swelling with CAPMATINIB
12.3%
of all CAPMATINIB reports
10
Deaths
34
Hospitalizations
How Dangerous Is Peripheral swelling From CAPMATINIB?
Of the 283 reports, 10 (3.5%) resulted in death, 34 (12.0%) required hospitalization, and 3 (1.1%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
Yes, Peripheral swelling is listed as a known adverse reaction in the official FDA drug label for CAPMATINIB.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
Decreased appetite (95)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which CAPMATINIB Alternatives Have Lower Peripheral swelling Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN